ESKALITH Drug Patent Profile
✉ Email this page to a colleague
When do Eskalith patents expire, and what generic alternatives are available?
Eskalith is a drug marketed by Noven Therap and Jds Pharms and is included in three NDAs.
The generic ingredient in ESKALITH is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eskalith
A generic version of ESKALITH was approved as lithium carbonate by HIKMA on January 29th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ESKALITH?
- What are the global sales for ESKALITH?
- What is Average Wholesale Price for ESKALITH?
Summary for ESKALITH
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 13 |
| Patent Applications: | 2,019 |
| DailyMed Link: | ESKALITH at DailyMed |
Recent Clinical Trials for ESKALITH
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre for Addiction and Mental Health | Phase 4 |
| Patient-Centered Outcomes Research Institute | Phase 4 |
| Washington University School of Medicine | Phase 4 |
US Patents and Regulatory Information for ESKALITH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noven Therap | ESKALITH | lithium carbonate | CAPSULE;ORAL | 016860-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Jds Pharms | ESKALITH | lithium carbonate | TABLET;ORAL | 017971-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Jds Pharms | ESKALITH CR | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018152-001 | Mar 29, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
